[
  {
    "ts": null,
    "headline": "Bio-Techne: Recovery Likely Coming, But Is There Enough Re-Rating Potential?",
    "summary": "Bio-Techne stock has tailwinds in spatial biology and proteomics. Here's what investors need to know.",
    "url": "https://finnhub.io/api/news?id=cfd0ad652fdc70290391587c948a30ae47842583761a57bca9bdc9d008c082d9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767878908,
      "headline": "Bio-Techne: Recovery Likely Coming, But Is There Enough Re-Rating Potential?",
      "id": 138038994,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1158724314/image_1158724314.jpg?io=getty-c-w1536",
      "related": "TECH",
      "source": "SeekingAlpha",
      "summary": "Bio-Techne stock has tailwinds in spatial biology and proteomics. Here's what investors need to know.",
      "url": "https://finnhub.io/api/news?id=cfd0ad652fdc70290391587c948a30ae47842583761a57bca9bdc9d008c082d9"
    }
  }
]